EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Cell factory engineering: Challenges and opportunities for synthetic biology applications

Bhagyashree Bachhav, Jacopo de Rossi, Carlos D Llanos, Laura Segatori iD

Biotechnology and Bioengineering · 2023

DOI: 10.1002/bit.28365 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biotechnology and Bioengineering, 2023. Verfasst von Bhagyashree Bachhav und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biochemical Engineering, Rice University, Houston, Texas, USA. Hauptthemen laut MEDLINE: Synthetic Biology, Cell Engineering. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The production of high‐quality recombinant proteins is critical to maintaining a continuous supply of biopharmaceuticals, such as therapeutic antibodies. Engineering mammalian cell factories presents a number of limitations typically associated with the proteotoxic stress induced upon aberrant accumulation of off‐pathway protein folding intermediates, which eventually culminate in the induction of apoptosis. In this review, we will discuss advances in cell engineering and their applications at different hierarchical levels of control of the expression of recombinant proteins, from transcription and translational to posttranslational modifications and subcellular trafficking. We also highlight challenges and unique opportunities to apply modern synthetic biology tools to the design of programmable cell factories for improved biomanufacturing of therapeutic proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Synthetic BiologyCell EngineeringAnimalsRecombinant ProteinsProtein Processing, Post-TranslationalMetabolic EngineeringMammals

Stichwörter der Autor:innen

cell engineeringgenetic engineeringmammalian cell factoriesmammalian synthetic biologyrecombinant proteins

Substanzen

Recombinant Proteins

Autor:innen und Institutionen

  • Department of Chemical and Biochemical Engineering, Rice University, Houston, Texas, USA.
  • Systems, Synthetic, and Physical Biology, Rice University, Houston, Texas, USA.
  • Department of Bioengineering, Rice University, Houston, Texas, USA.
  • Department of Biosciences, Rice University, Houston, Texas, USA.

ORCID-Profile: Laura Segatori

Förderung

  • NIBIB NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Bachhav, B., de Rossi, J., Llanos, C. D., & Segatori, L. (2023). Cell factory engineering: Challenges and opportunities for synthetic biology applications. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28365

Vancouver

Bachhav B, de Rossi J, Llanos CD, Segatori L. Cell factory engineering: Challenges and opportunities for synthetic biology applications. Biotechnology and Bioengineering. 2023. doi:10.1002/bit.28365

BibTeX
@article{Bachhav2023,
  author = {Bachhav, Bhagyashree and de Rossi, Jacopo and Llanos, Carlos D and Segatori, Laura},
  title = {Cell factory engineering: Challenges and opportunities for synthetic biology applications},
  journal = {Biotechnology and Bioengineering},
  year = {2023},
  doi = {10.1002/bit.28365}
}
Kostenlos starten →